Nexien BioPharma, Inc.
NXEN
$0.0095
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.30K | 5.00K | 4.20K | 10.10K | 2.60K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 4.20K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.30K | 5.00K | 4.20K | 14.30K | 2.60K |
|
|
|||||
| Total Current Assets | 1.30K | 5.00K | 4.20K | 14.30K | 2.60K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.30K | 5.00K | 4.20K | 14.30K | 2.60K |
|
|
|||||
| Total Accounts Payable | 73.00K | 68.40K | 53.20K | 44.50K | 36.40K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 351.00K | 328.30K | 312.30K | 295.00K | 280.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 424.00K | 396.70K | 365.40K | 339.60K | 316.80K |
|
|
|||||
| Total Current Liabilities | 424.00K | 396.70K | 365.40K | 339.60K | 316.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 351.00K | 328.30K | 312.30K | 295.00K | 280.50K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 424.00K | 396.70K | 365.40K | 339.60K | 316.80K |
|
|
|||||
| Common Stock & APIC | 11.18M | 11.17M | 11.17M | 11.12M | 11.08M |
| Retained Earnings | -11.61M | -11.57M | -11.53M | -11.45M | -11.39M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -422.70K | -391.80K | -361.20K | -325.30K | -314.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -422.70K | -391.80K | -361.20K | -325.30K | -314.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -422.70K | -391.80K | -361.20K | -325.30K | -314.20K |
|
|
|||||